---
$id: https://graph.org.ai/products/commodity/51141524
$type: Product
source: UNSPSC
code: "51141524"
title: "Phenacemide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Phenacemide

**UNSPSC Code**: 51141524
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C9H10N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PAI7J52V09, chemically known as urea, (phenylacetyl)- but generally known as phenacemide, which bears US NIH Compound Identifier 4753. European Medicines Agency schedules Phenacemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09744MIG. The term PHENACEMIDE is an International Non-Proprietary Name. World Health Organization schedules phenacemide in its Anatomical Therapeutic Chemical (ATC) Classification. PHENACEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenacemide under HS 29242995 and SITC 51479. As of Q4 2014, PHENACEMIDE remains the US FDA Preferred Term for this commodity. Phenacemide bears US NLM identifiers UMLS ID C0070525 and NCI Concept Code C66363. SMILES: O=C(NC(=O)N)CC1CCCCC1.

